ORIC

Oric Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 3/10
  • Value↑ 5/10
Oric Pharmaceuticals sales and earnings growth
ORIC Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 19.67%
  • FCF Y/Y↓ 1.90%
Oric Pharmaceuticals gross and profit margin trends
ORIC Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -52.38%
Oric Pharmaceuticals net debt vs free cash flow
ORIC Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Oric Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗